| Year |
Citation |
Score |
| 2018 |
Goodwin CR, Rath P, Oyinlade O, Lopez H, Mughal S, Xia S, Li Y, Kaur H, Zhou X, Ahmed AK, Ho S, Olivi A, Lal B. Crizotinib and erlotinib inhibits growth of c-Met/EGFRvIII primary human glioblastoma xenografts. Clinical Neurology and Neurosurgery. 171: 26-33. PMID 29803091 DOI: 10.1016/j.clineuro.2018.02.041 |
0.382 |
|
| 2018 |
Oyinlade O, Wei S, Lal B, Laterra J, Zhu H, Goodwin CR, Wang S, Ma D, Wan J, Xia S. Targeting UDP-α-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration. Oncogene. PMID 29479058 DOI: 10.1038/s41388-018-0138-y |
0.527 |
|
| 2016 |
Goodwin CR, Woodard CL, Zhou X, Pan J, Olivi A, Xia S, Bettegowda C, Sciubba DM, Pevsner J, Zhu H, Laterra J. Microarray-Based Phospho-Proteomic Profiling of Complex Biological Systems. Translational Oncology. 9: 124-9. PMID 27084428 DOI: 10.1016/J.Tranon.2016.02.001 |
0.535 |
|
| 2016 |
Goodwin CR, Liang L, Abu-Bonsrah N, Hdeib A, Elder BD, Kosztowski T, Bettegowda C, Laterra J, Burger P, Sciubba DM. Extraneural Glioblastoma Multiforme Vertebral Metastasis. World Neurosurgery. 89: 578-582.e3. PMID 26704201 DOI: 10.1016/J.Wneu.2015.11.061 |
0.473 |
|
| 2015 |
Xia S, Lal B, Tung B, Wang S, Goodwin CR, Laterra J. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation. Neuro-Oncology. PMID 26320116 DOI: 10.1093/neuonc/nov171 |
0.526 |
|
| 2013 |
Woodard CL, Goodwin CR, Wan J, Xia S, Newman R, Hu J, Zhang J, Hayward SD, Qian J, Laterra J, Zhu H. Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling. Plos One. 8: e72671. PMID 24023761 DOI: 10.1371/Journal.Pone.0072671 |
0.503 |
|
| 2012 |
Wang SD, Rath P, Lal B, Richard JP, Li Y, Goodwin CR, Laterra J, Xia S. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene. 31: 5132-43. PMID 22310282 DOI: 10.1038/onc.2012.16 |
0.571 |
|
| 2011 |
Goodwin CR, Lal B, Ho S, Woodard CL, Zhou X, Taeger A, Xia S, Laterra J. PTEN reconstitution alters glioma responses to c-Met pathway inhibition. Anti-Cancer Drugs. 22: 905-12. PMID 21654317 DOI: 10.1097/Cad.0B013E3283484750 |
0.572 |
|
| 2011 |
Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene. 30: 3454-67. PMID 21383690 DOI: 10.1038/Onc.2011.58 |
0.55 |
|
| 2010 |
Goodwin CR, Laterra J. Neuro-oncology: unmasking the multiforme in glioblastoma. Nature Reviews. Neurology. 6: 304-5. PMID 20531430 DOI: 10.1038/Nrneurol.2010.67 |
0.497 |
|
| 2010 |
Goodwin CR, Lal B, Zhou X, Ho S, Xia S, Taeger A, Murray J, Laterra J. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation. Cancer Research. 70: 2932-41. PMID 20233866 DOI: 10.1158/0008-5472.Can-09-3570 |
0.586 |
|
| 2009 |
Lal B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim J, Laterra J. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Molecular Cancer Therapeutics. 8: 1751-60. PMID 19584231 DOI: 10.1158/1535-7163.Mct-09-0188 |
0.611 |
|
| 2008 |
Li Y, Fan X, Goodwin CR, Laterra J, Xia S. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5. Bmc Cancer. 8: 325. PMID 18992144 DOI: 10.1186/1471-2407-8-325 |
0.537 |
|
| 2008 |
Cornet K, Lal B, Goodwin C, Laterra J. Systemic Delivery of Anti-HGF Monoclonal Antibody Inhibits Glioma Growth Through Downstream Oncogenic Signaling Molecules Planta Medica. 74. DOI: 10.1055/S-2008-1075233 |
0.526 |
|
| Show low-probability matches. |